Head & Neck · 2018 · 29 citations · 32 references
MedicineOncologySurgeryNeck OncologyOncologic SurgerySurgical OncologyEwing SarcomaSarcoma SurgeryEwing Sarcoma ChemotherapyEwing Sarcoma RecurrenceEwing Sarcoma TreatmentHead And Neck Sarcoma SurgeryMargin-negative ResectionMultimodality Cancer TherapyRecurrence-free SurvivalSurgical Resection Margins
BACKGROUND: Treatment options of Ewing sarcoma of the head and neck include surgery, radiotherapy (RT), and chemoradiotherapy. However, local control can be challenging. METHODS: We conducted a retrospective review of all patients with head and neck Ewing sarcoma treated from 1972 to 2015 at a single tertiary care hospital. RESULTS: Seventeen patients met criteria (median 21 years, range 5-58 years; 5 women). Mean follow-up was 10.4 years (range 2.2-39 years). Tumors occurred commonly in the cervical spine (5/17), the skull (3/17), and the paranasal sinuses (3/17). A total of 14 of 17 patients underwent surgical resection, 9 with gross total resection. After multimodality therapy, the 5-year overall survival (OS) and recurrence-free survival (RFS) was 87% and 75%, respectively. CONCLUSION: Combined multimodal treatment resulted in a 5-year OS and RFS of 87% and 75%, respectively. Aggressive surgical resection with adjuvant chemoradiotherapy should be considered. Although negative margin surgery is the goal, subtotal resection may be acceptable in the setting of adjuvant treatment.
32
Richard B. Womer, Daniel C. West, Mark Krailo et al. · Journal of Clinical Oncology · 2012 · 756 citations · Full text